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Background
Osteosarcoma (OS)
• Most common primary malignant tumor of bone in humans and dogs. 
• Rare (5th most common malignancy in children and adolescents) and 
commonly occurs in the metaphyseal area of long bones such as the proximal 
humerus, distal radius, distal femur, or proximal tibia.
• Overall survival rate is 65-70% in patients presenting without detectable 
metastases, survival rate plummets in patients who have macroscopic 
metastases at diagnosis.
• Prior work in both dogs and humans demonstrated that nearly all patients 
have micro-metastases present in the lungs at diagnosis. In a subsection of 
these patients, standard chemotherapy and surgery is insufficient to prevent 
development of chemoresistant macrometastases.
Hyaluronic Acid (Hyaluronan, HA) 
• Major structural component of the extracellular matrix (ECM), found 
specifically in the extracellular, pericellular, and intracellular matrices.
• Physical properties of hyaluronic acid are taken advantage of by the tumor 
cells
• Compound can create a barrier in the extracellular matrix of the cell, 
only permitting small molecules like water to pass through. 
• In addition to its largely negative charge, creates a highly hydrodynamic 
space. Due to the influx of water into the cell, the interstitial volume in 
tumor cells is increased and this property limits drug penetrance
Aims
Use database query to examine the genetics of cell lines, specifically at 
alterations in hyaluronic acid synthesis, the hyaluronic acid/CD44 signaling axis, 
and genes known to be associated with either metastasis or chemotherapy 
resistance.
• Previous work showed promise for several candidate genes to focus the query 
on: HAS 1-3, CD44, MGST1, EPHA2, and SGCD.
• MGST1, EPHA2, and SGCD are candidate early-chemotherapy-
response genes that were upregulated in a pilot Sleeping Beauty forward 
genetic screen that compared the genetics of tumors treated with 
chemotherapy with untreated tumors
• HAS 1, 2, and 3 had increased expression in chemotherapy-treated samples 
and have been previously identified as potential contributors to 
chemotherapy resistance in other cancers.
Methods
Using the program R Studio and the package BiocManager, osteosarcoma cell lines 
were viewed through the Cancer Cell Line Encyclopedia and ones that have 
alterations in any of the above-mentioned genes were identified. Then further 
coding was used to search through DepMap identify and eliminate essential genes 
that are required for life. The result was a list of cell lines in which one or more of 
our candidate genes would be essential to only those cells. After identifying these 
cell lines, a program, EnrichR, was used to see if there was validity in the results.
Figure 1: Graphic for overview of project methods
Findings
Conclusions
There were a total of 10 genes and 11 genes, for HAS1-3 and our candidate 
genes, respectively, that were found to be essential for those cell lines of 
interest. After placing these genes into EnrichR, it was found that For the cell 
lines without HAS1-3, the genes were highly important for immune response and 
cell adhesion molecules, which directly affect cancer metastasis. For the cell lines 
without the initial candidate genes, PI3K-AKT signaling as well as general signal 
transduction were impacted by these genes. This shows that a KO of these genes 
would result in improper signaling within pathways important for cell growth and 
signal transduction. 
Overall, the results did acknowledge that HAS1-3 and our candidate genes 
heavily influence osteosarcoma metastasis due to what processes they impact 
when knocked out.
Future Studies
While this information provides a good starting basis for our research, it does not 
replace work in the lab. Part of the future directions would include replicating 
this experiment in the lab setting and comparing the results to this 
bioinformatics study.
Another future study would be to take this concept, if it proves to be effective, 
implement it into mouse models to further determine if this is an effective 
method against Osteosarcoma macroscopic metastases.
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